BioMed Research International

BioMed Research International / 2009 / Article

Research Article | Open Access

Volume 2009 |Article ID 274740 |

Edvaldo Rodrigues de Almeida, Krissia Rayane de Oliveira Rafael, Geraldo Bosco Lindoso Couto, Ana Beatriz Matos Ishigami , "Anxiolytic and Anticonvulsant Effects on Mice of Flavonoids, Linalool, and 𝛼 -Tocopherol Presents in the Extract of Leaves of Cissus sicyoides L. (Vitaceae)", BioMed Research International, vol. 2009, Article ID 274740, 6 pages, 2009.

Anxiolytic and Anticonvulsant Effects on Mice of Flavonoids, Linalool, and 𝛼 -Tocopherol Presents in the Extract of Leaves of Cissus sicyoides L. (Vitaceae)

Academic Editor: Omar Benzakour
Received06 Sep 2008
Revised07 Nov 2008
Accepted15 Dec 2008
Published12 Mar 2009


The aim of the present study is to demonstrate the anxiolytic and anticonvulsant effects of a hydroalcoholic extract obtained from the aerial parts of Cissus sicyoides L. (CS) (Vitaceae) on male and female mice using several behavioral assays. Groups of males and females treated via intraperitoneal (IP) with doses of 300, 600, and 1000 mg/kg of the extract showed significant action in the elevated plus-maze (EPM), time spent in the open arms, and number of entries in the open arms. The board-hole test also showed a significant increase in the time spent in head-dipping and in marble-burying test of the number of marbles buried. The same treatment increased the duration of sleeping time induced by sodium pentobarbital and also showed a significant increase in protection against pentylenotetrazole-induced convulsions. These results indicate an anxiolytic and anticonvulsant-like action from C. sicyoides L. extract on mice, probably due to the action of flavonoid(s), Linalool, and -tocopherol present in the C. sicyoides leaves.

1. Introduction

Cissus sicyoides (CS) belonging to the Vitaceae family comprises of about 165 genus and 1370 species, which are distributed throughout the tropics, mainly in Brazil and the Caribbean. It is popularly known as “insulinas, cipo-pucá, bejuco de porra, bejuco caro, puci, and anil trepador” [1]. Originally from the Dominican Republic [2], it is used in popular medicine as a diuretic, anti-inflammatory, and antidiabetic [3, 4]. It has also demonstrated a vasoconstrictor effect on guinea-pig aorta rings [5] and an antibacterial activity [6]. In Brazil, CS was evaluated for its anticonvulsant property, where it is used against epilepsy andcytotoxic activities [79]. The fact that treatment with tea induced an increase in the amount of chromosomal damage in bone marrow cells without altering the cell division cycle was also demonstrated. This plant also presents antibacterial and oxytocic activities [10], and CS contains significant amounts of α-tocoferol, a compound proved to be a useful adjunct to anticonvulsants in clinical medicine [11]. Alpha-tocopherol protects against pentylenotetrazol and methylmalonate-induced convulsions [12] and prevents the occurrence of epileptic foci in a rat model of posttraumatic epilepsy [13]. The central antinociceptive effect of C. sicyoides on mice as well as the action of dry leaves extract in pregnant rats and offspring postal development was also demonstrated. [1416]. Phytochemistry studies identified and isolated from the aerial parts of CS a new coumarin glycoside 5,6,7,8-tetrahydroxycoumarin-5β-xylopyranoside which was obtained together with known coumarin sabandin, two flavonoids kaempferol 3-rhamnoside and quercetin 3-rhamnoside, and two steroids, sitosterol and 3β-O-β-d-glucopyranosylsitosterol [17] (see Figure 1). Leaves of the genus Cissus contain sterols, quinones, and phenolic compounds. Anthocyanins, saponins, and flavonoids are also found in the plants leaves and fruits [3]. The effect of linalool present in the leaves of the CS wasdemonstrated in the protection against seizures induced in mice [7, 8, 18] (see Figure 2). However, we found no reference on its activity on the central nervous system (CNS) relating to anxiety as well as information on its acute toxicity. Benzodiazepines (BDZs) are considered safe drugs and are widely prescribed for their anxiolytic and anticonvulsant actions [1921]. However, they may produce side effects, such as sedation and myorelaxation that are considered as unwanted effects in an anxiolytic drugs [20]. On the other hand, the existence of natural flavonoids that possess anxiolytic effect not associated with myorelaxant, amnesic, or sedative actions has been demonstrated [22]. Although alternative treatments with herbs are increasingly used by the population to alleviate affective disorders, there is a strong rejection among doctors as the use of herbs for treatment of various diseases is still scarce [23]. The antidiabetic action of the CS is in the making of clinical trials (phase II), the results obtained by the authors are promising for the future use in medical clinics [24]. This study also aims to assess the possible effects of flavonoids in the hydroalcoholic extract of the CS leaves in several behavioral tests related to anxiety in mice. The presence of α-Tocopherol has been identified in the leaves of C. sicyoides, used in clinical practice as an adjunct in the treatment of seizures [11] (see Figure 3). Our result indicates a new action for use of the C. sicyoides which can be related to the presence of the α-tocopherol as an adjuvant of the effect of sedatives together with the linalool and flavonoids present in this plant.

2. Materials and Methods

2.1. Plant Material and Extract Preparation

Aerial parts of CS were collected in the vicinity of the campus of the Federal University of Pernambuco—State of Pernambuco—Brazil in January 2005. The plant was identified by University Prof. Marlene Carvalho de Alencar Barbosa, and a vouched for specimen was deposited in the Geraldo Mariz Herbarium (UFP) under Botanical Department N° 29040. The collected leaves were washed, dried at room temperature (28°C) in the laboratory for 25 days and ground in a mill to a grain size of <1 mm. Then, 360 grams of the powdered plant material were added to 1000 mL of alcohol and water (70:30, v/v). The dry powder yielded 30% of extract. For pharmacological testing, the extract was dissolved in saline plus Tween 80 (0.025%) solution.

2.2. Animals

Male and female two-month-old Swiss albino mice, weighing 20–30 g, were used in this experiment. The animals were housed in groups of ten per cage, with light/dark periods of 12 hours. They were fed and watered ad libitum. All experiments were conducted between 10:00 am and 4:00 pm. Female mice were tested without monitoring the oestrus cycle. All the animals were carefully monitored and maintained in accordance with the ethical recommendation of the Brazilian College of Animal Experimentation (COBEA) and the National Institute of Health Guide for Care and use of Laboratory Animals and approved by the Ethical Committee of the Federal University of Pernambuco (UFPE) protocol number 008196/2005-29.

2.3. Drugs

Diazepam (DPZ, 2.5 mg/kg, IP) was used as the standard anxiolytic drug. Pentobarbital sodium (PBS, 55 mg/kg, IP) was used as a hypnotic drug and pentylenotetrazole (PTZ, 55 mg/kg, IP) as a convulsant. All drugs were obtained from Sigma Aldrich, Mo, USA, and Tween 80 was locally purchased.

2.4. Sodium Pentobarbital-Induced Sleeping Time

The mice were divided into four groups (10 animals/group). Three groups received three doses of extract (300, 600, and 1000 mg/kg (IP). After 1 hour, all four groups received 55 mg/kg (IP) of sodium pentobarbital (PBS). The time that elapsed between the loss and recovery of the righting reflex was recorded, for control and drug pretreated animals [25].

2.5. Pentylenotetrazole-Induced Convulsion

The mice were divided into four groups (10 animals/group). The first group received the pentylenotetrazole (PTZ) (55 mg/kg IP) and served as positive control. The test groups received the CS extract at doses of 300, 600, and 1000 mg/kg (IP). After 1 hour, PTZ (55 mg/kg, IP) was administered to the animals in each group. The number of mice which exhibited convulsions, the lethal time, and the latency to first convulsion was recorded [25].

2.6. Marble-Burying Test

Twenty-five clear glass marbles (20 mm diameter) were used for each individual test. Opaque cages (  cm) were constructed of smooth, opaque plastic with a vinyl ceiling containing air holes, and a 5 cm layer of sawdust. Mice were placed individually in these cages for 15 minutes (habituation trial) and then returned to their home cage. Twenty-five glass marbles were evenly spaced 5 cm apart on a 5 cm layer of sawdust in the habituation cages. Mice were then reintroduced (each test mouse was returned to the same cage in which they had been habituated). 10 animals were used in each group. The test groups received the CS extract at doses of 300, 600, and 1000 mg/kg (IP). After 15 minutes, the test was terminated by removing the mice and counting the number of marbles that were more than two-thirds covered with sawdust. After each trial, the sawdust was replaced, and the test apparatus and glass marbles were washed by water and cleaned with 70% alcohol [26, 27].

2.7. Board-Hole Test

Exploratory behavior was assessed using the board-hole test [28]. The apparatus consisted of a square plastic plate, 40 cm × 40 cm, 1 cm thick, with 16 holes (diameter 2 cm), regularly spaced on the surface, at 3.5 cm from the edges. The apparatus was elevated to the height of 50 cm, in a dimly illuminated room. Mice were placed in the centre of the plate, and the number of head dips was immediately counted during two or three consecutive periods of 5 minutes each.

2.8. Elevated Plus-Maze Test

The elevated plus-maze (EPM) test consisted of two open arms (  cm) and two closed arms (  cm) emanating from a common central platform (  cm). Two pairs of identical arms were opposite to each other. The entire apparatus was elevated to a height of 40 cm above floor level. At the beginning of the session, a mouse was placed at the centre of the maze, its head facing an open arm and allowed to explore the maze for 5 minutes, and the following parameters were scored: the time spent and number of entries in each type of arms. The plus maze was carefully cleaned with a wet towel after each animal test. The mice were divided into four groups (10 animals/group). DPZ (2.5 mg/kg, IP) was used as the positive control and CS extract at doses of 300, 600, and 1000 mg/kg, i.p, in the three remaining groups. All experiments were carried out between 10:00 am and 4:00 pm. After each trial, the EPMapparatus was wiped clean with alcohol (70%) solution [29].

2.9. Statistical Analysis

Statistical analysis was performed using one-way ANOVA with post hoc Duncan's test. was considered significant. All data are expressed as mean ±S.D.

3. Results

3.1. Sodium Pentobarbital-Induced Sleeping Time

The effect of pentobarbital sodium-induced sleep is shown in Figure 1. The values, up to 1000 mg/kg of CS, were significantly different from the control group *[F (1.7) = 5.5; ].

3.2. Effect of CS Pentylenotetrazole(PTZ-) Induced Convulsion

The CS inhibited generalized clonic-tonic convulsions induced by PTZ (55 mg/kg, IP) at doses of 600 and 1000 mg/kg (Figure 5), as in accordance with statistical analysis *[F(1.6) = 5.7; ], using analysis of variance one way (ANOVA) and followed by a post hoc Duncan's test.

3.3. Marble-Burying Test

To examine this premise, we studied the effect of the representative of CS on burying behavior. As expected, control exhibited significant decrease in the marble burying behavior. However, CS prompted an increase in marble burying (300, 600, and 100 mg. k , IP. These data were evaluated using the analysis of variance one way (ANOVA) followed by a post hoc Duncan's tests. *[F (1.14) = 5.8; ], and **[F (1.12) = 5.7; ]  (Figure 6).

3.4. Effect of Board-Hole Test

The effect of CS on the board-hole test is shown in Figure 7. At the doses of 300, 600, and 100 mg/kg, IP, a significant increase in the amount of head-dipping behavior was shown *[F (1.13) = 5.7; ].

3.5. Effect of CS on the Elevated Plus-Maze (EPM)

CS in all the doses (300, 600, and 1000 mg/kg, IP) produced anxiolytic-like effects as determined by the increase in the percentage of open arm entries *[F (1.14) = 5.6; ]. Conversely, the number of entries and the time spent in the closed arms were reduced by CS treatment [F (1.13) = 5.5; ]  (Figures 8 and 9).

4. Discussion

C. sicyoides is a plant originating from the Dominican Republic [2]. It is popularly known as “insulina, cipo-pucá, bejuco de porra, bejuco caro, puci, and anil trepador” [1]. It is used in popular medicine as a diuretic, anti-inflammatory [4], and antidiabetic [5].

The aim of this study was to analyse the behavioral effects of the crude hydroalcoholic extract of the aerial parts of CS. The results presented here show that CS did not exhibit toxicity in mice and did not induce any significant changes in several behavioral and physiological parameters, and showed a slight decrease in spontaneous locomotor activity and an increase in breathing frequency (data not shown).

Treatment with CS reduced the latency of induction and increased the duration of the barbiturate-induced sleep (see Figure 3) indicating CNS depressant activity, since sleeping time induced by PBS is related to its central depressant properties. These finding suggest that C. sicyoides, administered by the intraperitoneal route, has hypnosedative activity due to the potential of barbiturate-induced sleep and might probably be due to pharmacokinetic interactions between CS and PBS through the presence of flavonoids, and mainly by linalool present in CS leaves [7, 8, 19].

In this regard, there are few reports showing pharmacokinetic interaction of other plant species, such as Smilax sp., Piper methysticum, among others, with therapeutic drugs such as diazepam, alcohol, barbiturates, and other psycho pharmacological agents [30, 31]. PBS is metabolized in the liver by an oxidative pathway that involves cytochrome , NADPH, and molecular [32]. A hypothesis to explain the enhanced barbiturate-induced sleep should be possible as an enzymatic inhibition of liver enzymatic systems, such as CYP 450, by CS, metabolizes intermediate and short-action barbiturates [25, 33]. CS produced a protection against convulsions induced by PTZ in mice *[F (1.6) = 5.7; ]  (see Figure 5).

CS also increased significantly the number of hidden glass marbles *[F (1.14) = 5.8; ], and [F (1.12) = 5.7; ]  (Figure 6). A significant increase in the exploratory head-dipping behavior was observed after the treatment with 300, 600, and 1000 mg/kg IP of the CS extract, thus reinforcing the anxiolytic-like activity *[F (1.13) = 5.7; ]  and **[F (1.12) = 5.7; ]  (Figure 7). On the other hand, several plants increased exploratory behavior of open arms in the EPM test and are generally used to diminish anxiety in folkloric medicine. Among them are Ginkgo biloba, Cassimiroa edulis [29, 33, 34]. In the EPM test, the effect of CS extract at doses of 300 and 600 mg/kg, IP was observed in the time spent in open arms *[F (1.13) = 5.7; ]  (see Figure 7).

The number of entries and the time spent in closed arms were reduced by the intraperitoneal treatment with CS (300, 600, and 1000 mg/kg) in comparison to the control values *[F (1.14) = 5.6; ]  and **[F (1.11) = 5.5; ]  (see Figure 8). The EPM test is designed to evaluate drugs with anxiolytic-like nonspecific action. Extract or drugs that increase the time spent in open arms are considered anxiolytic by withdrawal of fear in the animals. The same happens with time spent in the closed arms, which are considered to produce fear or anxiety [29].

In this study, diazepam was used as a positive control, and, as expected, it increased the activity in the open arms of the EPM apparatus, confirming anxiolytic-like actions. The presence of flavonoids, linalool, and α-tocopherol in C. sicyoides leaves reinforces the anxiolytic-like and anticonvulsant-like effects of this plant found by us in this study.


The authors wish to express their gratitude to National Council for Research (CNPq) and to the Federal University of Pernambuco for their support.


  1. F. L. Beltrame, J. L. Sartoretto, R. B. Bazotte, R. N. Cuman, and D. A. G. Cortez, “Estudo fitoquímico e avaliação do potencial antidiabético do Cissus sicyoidesL (Vitaceae),” Química Nova, vol. 24, no. 6, pp. 783–785, 2001. View at: Google Scholar
  2. J. H. Cano and G. Volpato, “Herbal mixtures in the traditional medicine of Eastern Cuba,” Journal of Ethnopharmacology, vol. 90, no. 2-3, pp. 293–316, 2004. View at: Publisher Site | Google Scholar
  3. M. C. F. Toledo, F. G. R. Reyes, M. Iaderoza, F. J. Fancis, and I. S. Draetta, “Anthocyanins from anil trepador (Cissus sicyoides, Linn.),” Journal of Food Science, vol. 48, no. 4, pp. 1368–1369, 1983. View at: Publisher Site | Google Scholar
  4. M. D. García, A. M. Quílez, M. T. Sáenz, M. E. Martínez-Domínguez, and R. de la Puerta, “Anti-inflammatory activity of Agave intermixta Trel. and Cissus sicyoides L., species used in the Caribbean traditional medicine,” Journal of Ethnopharmacology, vol. 71, no. 3, pp. 395–400, 2000. View at: Publisher Site | Google Scholar
  5. M. T. Pepato, A. M. Baviera, R. C. Vendramini, M. D. P. M. da Silva Perez, I. do Carmo Kettelhut, and I. L. Brunetti, “Cissus sicyoides (princess vine) in the long-term treatment of streptozotocin-diabetic rats,” Biotechnology & Applied Biochemistry, vol. 37, no. 1, pp. 15–20, 2003. View at: Publisher Site | Google Scholar
  6. M. D. Garcia, M. T. Saenz, R. Puerta, A. Quilez, and M. A. Fernandez, “Antibacterial activity of Agave intermixta and Cissus sicyoides,” Fitoterapia, vol. 70, no. 1, pp. 71–73, 1999. View at: Publisher Site | Google Scholar
  7. E. Elisabetsky, J. Marschner, and D. O. Souza, “Effects of linalool on glutamatergic system in the rat cerebral cortex,” Neurochemical Research, vol. 20, no. 4, pp. 461–465, 1995. View at: Publisher Site | Google Scholar
  8. E. Elisabetsky, G. P. Coelho de Souza, M. A. C. dos Santos, I. R. Siquieira, T. A. Amador, and D. S. Nunes, “Sedative properties of linalool,” Fitoterapia, vol. 66, no. 5, pp. 407–414, 1995. View at: Google Scholar
  9. M. T. Sáenz, M. D. Garcia, A. Quilez, and M. C. Ahumada, “Cytotoxic activity of Agave intermixta L. (Agavaceae) and Cissus sicyoides L. (Vitaceae),” Phytotherapy Research, vol. 14, no. 7, pp. 552–554, 2000. View at: Publisher Site | Google Scholar
  10. V. E. P. Vicentini, M. L. Camparoto, R. O. Teixeira, and M. S. Mantovani, “Averrhoa carambola L., Syzygium cumini (L.) Skeels and Cissus sicyoides L.: medicinal herbal tea effects on vegetal and animal test systems,” Acta Scientarium, vol. 23, no. 2, pp. 593–598, 2001. View at: Google Scholar
  11. W. L. R. Barbosa, Untersuchung der brasilianischen Arzneipflanze Cissus sicyoides, Ph.D dissertation, Bonn University, Bonn, Germany, 1994.
  12. M. C. P. Ribeiro, D. Silva de Ávila, C. Y. M. Schneider et al., “α-tocopherol protects against pentylenetetrazol- and methylmalonate-induced convulsions,” Epilepsy Research, vol. 66, no. 1–3, pp. 185–194, 2005. View at: Publisher Site | Google Scholar
  13. N. Yamamoto, H. Kabuto, S. Matsumoto, N. Ogawa, and I. Yokoi, “α-tocopheryl-L-ascorbate-2-O-phosphate diester, a hydroxyl radical scavenger, prevents the occurrence of epileptic foci in a rat model of post-traumatic epilepsy,” Pathophysiology, vol. 8, no. 3, pp. 205–214, 2002. View at: Publisher Site | Google Scholar
  14. E. R. de Almeida, R. P. F. Soares, F. F. R. Lucena, J. R. G. de Oliveira, J. F. C. Albuquerque, and G. B. L. Couto, “Central antinociceptive effects of Cissus sicyoides on mice,” Pharmaceutical Biology, vol. 44, no. 4, pp. 304–308, 2006. View at: Publisher Site | Google Scholar
  15. E. R. de Almeida, J. R. G. de Oliveira, F. F. R. Lucena, R. P. de Freitas Soares, and G. B. L. Couto, “The action of extract of the dry leaves of Cissus sicyoides L. in pregnant rats,” Acta Farmaceutica Bonaerense, vol. 25, no. 3, pp. 421–424, 2006. View at: Google Scholar
  16. E. R. de Almeida, J. R. G. Oliveira, F. R. S. Lucena et al., “Embriofetotoxic effect and offspring postnatal development exposed to hydroalcoholic fraction extract of Cissus sicyoides L. during wistar rats pregnancy,” Journal of Medicinal Plants Research, vol. 1, no. 5, pp. 109–112, 2007. View at: Google Scholar
  17. F. Beltrame, A. Ferreira, and D. Cortez, “Coumarin glycoside from Cissus sicyoides,” Natural Product Letters, vol. 16, no. 4, pp. 213–216, 2002. View at: Publisher Site | Google Scholar
  18. E. Elisabetsky, L. F. Brum, and D. O. Souza, “Anticonvulsant properties of linalool in glutamate-related seizure models,” Phytomedicine, vol. 6, no. 2, pp. 107–113, 1999. View at: Google Scholar
  19. E. A. Carlini, “Plants and the central nervous system,” Pharmacology Biochemistry and Behavior, vol. 75, no. 3, pp. 501–512, 2003. View at: Google Scholar
  20. J. H. Woods, J. L. Katz, and G. Winger, “Benzodiazepines: use, abuse, and consequences,” Pharmacological Reviews, vol. 44, no. 2, pp. 151–347, 1992. View at: Google Scholar
  21. D. W. Gallager and R. J. Primus, “Benzodiazepine tolerance and dependence: GABAA receptor complex locus of change,” Biochemical Society Symposium, vol. 59, pp. 135–151, 1993. View at: Google Scholar
  22. M. Marder and A. C. Paladini, “GABA-A-receptor ligands of flavonoid structure,” Current Topics in Medicinal Chemistry, vol. 2, no. 8, pp. 853–867, 2002. View at: Google Scholar
  23. E. Ernst, “Herb-drug interactions: potentially important but woefully under-researched,” European Journal of Clinical Pharmacology, vol. 56, no. 8, pp. 523–524, 2000. View at: Publisher Site | Google Scholar
  24. H. B. Santos, J. Modesto-Filho, M. D. F. F. M. Diniz et al., “Avaliação do efeito hipoglicemiante de Cissus sicyoides em estudos clínicos fase II,” Revista Brasileira de Farmacognosia, vol. 18, no. 1, pp. 70–76, 2008. View at: Google Scholar
  25. E. Speroni and A. Minghetti, “Neuropharmacological activity of extracts from Passiflora incarnata,” Planta Medica, vol. 54, no. 6, pp. 488–491, 1988. View at: Publisher Site | Google Scholar
  26. C. L. Broekkamp, H. W. Rijk, D. Joly-Gelouin, and K. L. Lloyd, “Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice,” European Journal of Pharmacology, vol. 126, no. 3, pp. 223–229, 1986. View at: Publisher Site | Google Scholar
  27. K. Njung'e and S. L. Handley, “Evaluation of marble-burying behavior as a model of anxiety,” Pharmacology Biochemistry and Behavior, vol. 38, no. 1, pp. 63–67, 1991. View at: Publisher Site | Google Scholar
  28. D. Treit, J. P. J. Pinel, and H. C. Fibiger, “Conditioned defensive burying: a new paradigm for the study of anxiolytic agents,” Pharmacology Biochemistry and Behavior, vol. 15, no. 4, pp. 619–626, 1981. View at: Publisher Site | Google Scholar
  29. R. G. Lister, “The use of a plus-maze to measure anxiety in the mouse,” Psychopharmacology, vol. 92, no. 2, pp. 180–185, 1987. View at: Publisher Site | Google Scholar
  30. R. U. Hasenöhrl, Ch. Nichau, Ch. Frisch et al., “Anxiolytic-like effect of combined extracts of zingiber officinale and ginkgo biloba in the elevated plus-maze,” Pharmacology Biochemistry and Behavior, vol. 53, no. 2, pp. 271–275, 1996. View at: Publisher Site | Google Scholar
  31. J. B. Harborne, Phytochemical Methods: A Guide to Modern Techniques of Plant Analysis, Chapman & Hall, London, UK, 1973.
  32. J. E. P. Toman and G. M. Everett, “Anticonvulsants,” in Evaluation of Drug Activities: Pharmacometrics, D. R. Lawrence and A. L. Bacharach, Eds., vol. 1, Academic Press, New York, NY, USA, 1964. View at: Google Scholar
  33. M. Blumenthal, The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines, American Botanical Council, Integrative Medicine Communications, Boston, Mass, USA, 2000.
  34. M. Molina-Hernández, N. P. Tellez-Alcántara, J. Pérez García, J. I. O. Lopez, and M. T. Jaramillo, “Anxiolytic-like actions of leaves of Casimiroa edulis (Rutaceae) in male Wistar rats,” Journal of Ethnopharmacology, vol. 93, no. 1, pp. 93–98, 2004. View at: Publisher Site | Google Scholar

Copyright © 2009 Edvaldo Rodrigues de Almeida et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles